Diaphragm Pacing Expansion Target institutions and clinicians involved in spinal cord injury, ALS, muscular dystrophy, and chronic respiratory insufficiency to expand adoption of the NeuRx Diaphragm Pacing System (DPS) and related devices across medical centers and specialty clinics.

Europe and Intl Growth Leverage the TransAeris and euRx DPS introductions to pursue international distributors and regional partners in Europe and other markets to accelerate market presence and device adoption.

Clinical Research Partnerships Collaborate with Case Western Reserve University and University Hospitals of Cleveland affiliates for ongoing clinical studies and real-world evidence to support reimbursement, regulatory approvals, and expanded indications.

Strategic Funding Signals Position SBI as a niche, high-impact medical device provider with proven research heritage to attract targeted investors or strategic partnerships, given the modest revenue footprint and growth potential in specialty respiratory support.

SME Efficiency Advantage Highlight the compact team size and specialized product focus to partner with large medical distributors and system integrators seeking high-value, high-margin specialty devices to complement their portfolio.